Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Buy
22,000
+693
+3% +$126K 0.08% 149
2026
Q1
$3.13M Buy
21,307
+6,807
+47% +$1.11M 0.09% 150
2025
Q4
$2.83M Buy
+14,500
New +$3.45M 0.08% 138
2019
Q1
Sell
-30,764
Closed -$1.39M 148
2018
Q4
$1.39M Sell
30,764
-122,696
-80% -$5.88M 0.05% 114
2018
Q3
$7.91M Buy
+153,460
New +$7.45M 0.41% 50
2018
Q2
Sell
-425,635
Closed -$19.5M 117
2018
Q1
$19.5M Buy
425,635
+94,582
+29% +$4.7M 1.08% 24
2017
Q4
$15.7M Buy
+331,053
New +$16.2M 1.22% 24

Other funds holding ORCL

Boaz Weinstein's ORCL Position: Q2 2026 in Review

Boaz Weinstein increased its Oracle (ORCL) stake by 3.3% in Q2 2026, buying an estimated $126K and bringing the position to 22,000 shares worth $3.22M. The position accounts for 0.08% of the portfolio, ranked #149.

Boaz Weinstein first reported a position in ORCL in Q4 2017 and has held it in 7 quarters since. The position peaked at $19.5M in Q1 2018. 3,504 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Boaz Weinstein held 22,000 shares of Oracle worth $3.22M as of Q2 2026.
  • Boaz Weinstein bought 693 Oracle shares in Q2 2026, an estimated $126K.
  • Oracle made up 0.08% of Boaz Weinstein's portfolio in Q2 2026, its #149 holding.
  • Boaz Weinstein first reported a position in Oracle in Q4 2017 and has held it in 7 quarters since.
  • Boaz Weinstein's Oracle position peaked at $19.5M in Q1 2018.
  • 3,504 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.